18 β‐Glycyrrrhetinic acid, a licorice compound, has been proven to inhibit the proliferation of GC cells by targeting the MAPK signaling pathway and regulating cytokines such as MRPL35, COPS5, TP53, thereby playing an anti‐GC role [122, 123]. This evidence concerns the gene TP53 and gastric cancer.